MRM Health was set up by Ghent spinout MRM Technologies to develop treatments based on the microbiome and has now concluded its first funding round backed by Qbic and VIB.

MRM Health, a Belgium-based developer of therapies based on the microbiome, secured €14m ($15m) in funding on Wednesday from investors including multi-university venture fund Qbic II and research institute VIB.
MRM Technologies, the holding company of gastrointestinal health platform ProDigest, also took part in the round, having set up MRM Health by spinning out certain assets of ProDigest.
DuPont Nutrition & Biosciences, a subsidiary of chemicals group DuPont, and diversified holding group Ackermans & van Haaren filled…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in